// App-Quantinova.ai

P4-01-16 : Detection of EMT, anoikis and stem cell markers in metastatic breast cancer patients under different lines of treatment

Researchers

Presenter

  • Trapp EK

Principal Investigators

  • Rack B

  • Majunke L

  • Friedl TWP

  • Neugebauer J

  • Jckstock J

  • Jger B

  • Huober J

  • Janni W

  • Alunni-Fabbroni M

  • Koch J

  • Hofmann S

Medical Centers

  • Ludwig-Maximilians-University, University Hospital, Munich, Germany

  • University of Ulm, Ulm, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Bone metastases

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

  • Cluster of Differentiation 24

  • Cluster of Differentiation 44

  • Cluster of differentiation 45

  • Progesterone receptor

  • Prominin 1

  • Cytokeratin 18

  • Cytokeratin 19

  • Epithelial Cell Adhesion Molecule

  • Vimentin

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A